Figure 6
From: The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
Methylation of the CD133 P2 promoter in ovarian (OVCAR-8 and IGROV-1) and endometrial (Ishikawa) cancer cell lines before and after treatment with 5-aza2‵-deoxycytidine (DAC) and Trichostatin A (TSA). * Representative results of real-time PCR analysis revealing CD133 promoter methylation in three cell lines with or without 5-aza-2`-deoxycytidine (DAC) and Trichostatin A (TSA). * Results are representative of three independent experiments.